FILTER
FILTERED INTERVIEW RESULTS
Dr. Seyfullah Dağıstanlı & Aytek Dağıstanlı
FOUNDER & BUSINESS DEVELOPMENT MANAGER, DELTAPV
DeltaPV is Turkey’s leading provider of pharmacovigilance in Turkey and exports its services abroad.
Peter Meath
MANAGING DIRECTOR & CO-HEAD OF HEALTHCARE AND LIFE SCIENCES, J.P. MORGAN COMMERCIAL BANKING
.P.Morgan explains the complete ecosystem that it has developed for life science companies, aiming to serve their needs throughout their entire life cycle, from opening a bank account on Day 1, to expanding internationally and through a potential IPO and beyond.
Ferhat Farsi
CEO AND CO-FOUNDER, CINNAGEN
CinnaGen Co. was founded in 1994 with the goal of manufacturing hi-tech products in biotechnology and related fields.
Fatih Yedikardeş
GENERAL MANAGER, DAIICHI SANKYO
Daiichi is a global pharmaceutical company that is developing Turkey as a regional hub.
Bharat Desai
MANAGING DIRECTOR, BHARAT PARENTERALS LIMITED
Bharat Parenterals is a research driven pharmaceutical company with a dedicated facility for antiretroviral drugs as well as a facility for general and B-lactam group of drugs.
John Patrick Oroho
EXECUTIVE VICE PRESIDENT AND CHIEF STRATEGY OFFICER, PORZIO LIFE SCIENCES, LLC
Porzio Life Sciences, LLC (PorzioLS) is a provider of compliance operations products and services for the life sciences industry, and a wholly‐owned subsidiary of the Porzio, Bromberg & Newman, P.C. law firm.
Zafer Toksoz
CHAIRMAN, ARVEN PHARMACEUTICALS
Arven Pharmaceuticals is an R&D based high-tech pharmaceutical company with a focus on research and development, manufacturing and marketing of high-tech pharmaceutical products, including biotech drugs and multi-dose innovative devices for dry powder inhalers.
Enrique Häusermann
PRESIDENT, ASSOCIAZIONE NAZIONALE INDUSTRIE FARMACI GENERICI E BIOSIMILARI (ASSOGENERICI)
Assogenerici is the Italian association that represents the country’s generic and biosimilar pharmaceutical industry.
Süha Taşpolatoğlu
CEO, ABDI IBRAHIM
Abdi İbrahim was founded in 1912 and has been the leader of Turkey’s Pharmaceutical Industry for 17 years, and boasts the largest product portfolio in the sector, with more than 200 brands and over 450 products.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
